Comparing methods to classify admitted patients with SARS-CoV-2 as admitted for COVID-19 versus with incidental SARS-CoV-2: A cohort study
Open Access
- 26 September 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (9) , e0291580
Abstract
Introduction: Not all patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop symptomatic coronavirus disease 2019 (COVID-19), making it challenging to assess the burden of COVID-19-related hospitalizations and mortality. We aimed to determine the proportion, resource utilization, and outcomes of SARS-CoV-2 positive patients admitted for COVID-19, and assess the impact of using the Center for Disease Control’s (CDC) discharge diagnosis-based algorithm and the Massachusetts state department’s drug administration-based classification system on identifying admissions for COVID-19. Methods: In this retrospective cohort study, we enrolled consecutive SARS-CoV-2 positive patients admitted to one of five hospitals in British Columbia between December 19, 2021 and May 31,2022. We completed medical record reviews, and classified hospitalizations as being primarily for COVID-19 or with incidental SARS-CoV-2 infection. We applied the CDC algorithm and the Massachusetts classification to estimate the difference in hospital days, intensive care unit (ICU) days and in-hospital mortality and calculated sensitivity and specificity. Results: Of 42,505 Emergency Department patients, 1,651 were admitted and tested positive for SARS-CoV-2, with 858 (52.0%, 95% CI 49.6–54.4) admitted for COVID-19. Patients hospitalized for COVID-19 required ICU admission (14.0% versus 8.2%, p<0.001) and died (12.6% versus 6.4%, p<0.001) more frequently compared with patients with incidental SARS-CoV-2. Compared to case classification by clinicians, the CDC algorithm had a sensitivity of 82.9% (711/858, 95% CI 80.3%, 85.4%) and specificity of 98.1% (778/793, 95% CI 97.2%, 99.1%) for COVID-19-related admissions and underestimated COVID-19 attributable hospital days. The Massachusetts classification had a sensitivity of 60.5% (519/858, 95% CI 57.2%, 63.8%) and specificity of 78.6% (623/793, 95% CI 75.7%, 81.4%) for COVID-19-related admissions, underestimating total number of hospital and ICU bed days while overestimating COVID-19-related intubations, ICU admissions, and deaths. Conclusion: Half of SARS-CoV-2 hospitalizations were for COVID-19 during the Omicron wave. The CDC algorithm was more specific and sensitive than the Massachusetts classification, but underestimated the burden of COVID-19 admissions. Trial registration: Clinicaltrials.gov, NCT04702945.Keywords
Funding Information
- Canadian Institutes of Health Research (447679)
- Canadian Institutes of Health Research (464947 & 466880)
- Ontario Ministry of Colleges and Universities (C-655-2129)
- Saskatchewan Health Research Foundation (5357)
- Genome British Columbia (COV024)
- Genome British Columbia (VAC007)
- Fondation du CHU de Québec (Octroi No. 4007)
- Public Health Agency of Canada (2122-HQ-000054)
- British Columbia Academic Health Science Network
- Biotalent Canada
This publication has 20 references indexed in Scilit:
- COVID-19 will continue but the end of the pandemic is nearThe Lancet, 2022
- The COVID-19 hospitalization metric in the pre- and postvaccination eras as a measure of pandemic severity: A retrospective, nationwide cohort studyInfection Control & Hospital Epidemiology, 2022
- Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africaInternational Journal of Infectious Diseases, 2021
- CCEDRRN COVID-19 Infection Score (CCIS): development and validation in a Canadian cohort of a clinical risk score to predict SARS-CoV-2 infection in patients presenting to the emergency department with suspected COVID-19BMJ Open, 2021
- Ensuring trust in COVID-19 dataMedicine, 2021
- Development of the Canadian COVID-19 Emergency Department Rapid Response Network population-based registry: a methodology studyCMAJ Open, 2021
- Patient characteristics associated with COVID-19 positivity and fatality in Nigeria: retrospective cohort studyBMJ Open, 2020
- The reliability of the Canadian triage and acuity scale: Meta-analysisNorth American Journal of Medical Sciences, 2015
- The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trialsEurosurveillance, 2013
- Measuring nominal scale agreement among many raters.Psychological Bulletin, 1971